Professional Documents
Culture Documents
Management:
Overall treatment includes hormone replacement therapy
and a low calorie diet is indicated promote weight loss.
Nursing Interventions
Management of disease
Surgical therapy—Most effective treatment for both
hyper and hypoparathyroidism. Leads to a rapid
reduction of chronically high calcium levels.
Criteria for surgery
• Serum calcium levels >12 mg/dl)
• Hypercalciuria (> 400 mg/dl)
• Markedly reduced bone mineral density
• Overt symptoms (neuromuscular effects,
nephrolithiasis)
• Those over age 50
*If autotransplantation of normal parathyroid tissue in the
forearm is done, the patient will be able to maintain
normal PTH secretion and calcium levels. If not then the
patient will need to take calcium supplements for life.
Nonsurgical therapy
Annual exam for tests for serum PTH, calcium,
phosphorus, and alkaline phosphatase levels; renal
function; x-rays to assess for metabolic bones loss and
measurement of urinary calcium excretion.
Continued ambulation and avoidance of immobility
Drugs that are helpful in lowering calcium levels include:
• Bisphosphonates (alendronate[Fosamax])—Inhibit
bone resorption and normalize serum calcium levels.
• Estrogen or progesterone can reduce serum and
urinary calcium levels in the premenopausal woman.
• Oral phosphates may be used to inhibit calcium
absorbing effects of vitamin D in the intestine.
ALERT: Phosphates should only be used if the
patient has normal renal function and low serum
phosphate levels.
• Diuretics may also be used to increase urination and
aid in excretion of calcium.
• Calcimimetic agents (cinacalcet [Sensipar]) are a
new class of drugs that increase the sensitivity of the
calcium receptor on the parathyroid gland, resulting
in decreased PTH secretion and calcium blood levels
and sparing calcium stores in the bone.
NURSING INTERVENTIONS:
• Monitor for postop (parathyroidectomy)
complications including hemorrhage, and fluid and
electrolyte imbalances.
• Monitor for tetany which is due to a sudden
decrease in calcium levels.
• Mild S/S of tetany includes tingling of hands and
around the mouth. More severe S/S includes
muscular spasms or laryngospasms. IV calcium
gluconate or gluceptate can be given for acute
tetany.
• Monitor intake and output. Monitor calcium,
phosphate, potassium, and magnesium levels
frequently. Also monitor for Chvostek’s and
Trousseau’s signs. Mobility is also encouraged.
• If surgery is not performed the nurse should relieve
the symptoms and prevent complications.
• Adapting a meal plan to the patient’s lifestyle,
referral to a dietitian and an exercise program should
be included.
• Encourage patient to keep appointments and explain
all tests being performed.
• Patients should also be taught the S/S of
hypocalcemia and hypercalcemia and report these
symptoms if noticed.
Hypoparathyroidism
Condition associated with inadequate circulating PTH. It
is characterized by hypocalcemia resulting from a lack of
PTH to maintain serum calcium levels.
Cause
Most common cause is iatrogenic. This may include
accidental removal of the parathyroid glands or damage
to the vascular supply of the glands during neck surgery.
Severe hypomagnesemia can also lead to a suppression
of PTH secretion.
Clinical Manifestations
• Sudden decrease in calcium can cause tetany. This
causes tingling of the lips, fingertips, and feet and
increased muscle tension leading to paresthesias and
stiffness.
• Painful tonic spasms of smooth and skeletal muscles,
dysphagia, laryngospasms.
• Chavostek’s sign and Trousseau’s sign are usually
positive.
• Respiratory function may be compromised and
patients are usually anxious and apprehensive.
• Abnormal lab values include decreased serum
calcium and PTH levels and increased serum
phosphate levels.
Management
• Management is to treat the acute complications of
tetany, maintain normal serum calcium levels, and
prevent long-term complications. Emergency
treatment of tetany requires calcium IV.
• Rebreathing may partially alleviate acute
neuromuscular symptoms associate d with
hypocalcemia such a as generalized muscle cramps
or mild tetany.
• Vitamin D is used in chronic and resistant
hypocalcemia to enhance intestinal calcium
absorption and bone resorption.
• With vitamin D therapy, preferred preparations are
dihydrotachysterol (Hytakerol) and 1,25-
dihydroxycholecalciferol (calcitrol [Rocaltrol]). These
drugs raise calcium levels and are quickly
metabolized.
• Ergocalciferol (Calciferol) is the least expensive of
the vitamin D preparations and may also be
prescribed.
• A lower pH enhances the degree of ionization of
calcium causing an increase in the proportion of total
body calcium available in the active form. This will
temporarily relieve the manifestations of
hypocalcemia.
• PTH replacement is not usually recommended
because of the expense and the need for parenteral
administration. Oral calcium supplement of at least
1.5-3 g/day in divided doses are usually prescribed.
Nursing Interventions
• IV calcium chloride, calcium gluconate, or calcium
gluceptate should be given slowly. Calcium is
infused slowly because blood levels can cause
hypotension, serious cardiac dysrhythmia, or cardiac
arrest.
• EKG monitoring is necessary when infusing calcium.
• IV patency should be assessed and monitored
throughout infusion because IV calcium can cause
venous irritation and inflammation. Extravasation
may cause cellulitis, necrosis, and tissue sloughing
so monitor.
• Instruct patient in management of long term drug
therapy and nutrition.
• Patients should include a high calcium meal plan in
their diet. This includes foods such as dark green
vegetables, soybeans, and tofu
• Patients should be told that foods containing oxalic
acid (spinach, rhubarb), phytic acid (bran, whole
grains), and phosphorous reduce calcium absorption.
• Teach patients about the need for lifelong treatment
and follow up care including the monitoring of
calcium levels there to four times a year.